rs766772102

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_001099922.3(ALG13):​c.1922A>G​(p.His641Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,209,507 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H641D) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000021 ( 0 hom. 7 hem. )

Consequence

ALG13
NM_001099922.3 missense

Scores

4
13

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.30

Publications

2 publications found
Variant links:
Genes affected
ALG13 (HGNC:30881): (ALG13 UDP-N-acetylglucosaminyltransferase subunit) The protein encoded by this gene is a subunit of a bipartite UDP-N-acetylglucosamine transferase. It heterodimerizes with asparagine-linked glycosylation 14 homolog to form a functional UDP-GlcNAc glycosyltransferase that catalyzes the second sugar addition of the highly conserved oligosaccharide precursor in endoplasmic reticulum N-linked glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
ALG13 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 36
    Inheritance: XL Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08782667).
BP6
Variant X-111727001-A-G is Benign according to our data. Variant chrX-111727001-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 383125.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAdExome4 allele frequency = 0.0000209 (23/1097871) while in subpopulation AMR AF = 0.000596 (21/35207). AF 95% confidence interval is 0.000399. There are 0 homozygotes in GnomAdExome4. There are 7 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Hemizygotes in GnomAdExome4 at 7 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG13NM_001099922.3 linkc.1922A>G p.His641Arg missense_variant Exon 16 of 27 ENST00000394780.8 NP_001093392.1 Q9NP73-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG13ENST00000394780.8 linkc.1922A>G p.His641Arg missense_variant Exon 16 of 27 2 NM_001099922.3 ENSP00000378260.3 Q9NP73-1

Frequencies

GnomAD3 genomes
AF:
0.00000896
AC:
1
AN:
111636
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000950
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000101
AC:
18
AN:
179073
AF XY:
0.0000897
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000621
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000225
GnomAD4 exome
AF:
0.0000209
AC:
23
AN:
1097871
Hom.:
0
Cov.:
30
AF XY:
0.0000193
AC XY:
7
AN XY:
363315
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26396
American (AMR)
AF:
0.000596
AC:
21
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19384
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54141
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40522
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4133
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
841811
Other (OTH)
AF:
0.0000434
AC:
2
AN:
46071
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000896
AC:
1
AN:
111636
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
33820
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30656
American (AMR)
AF:
0.0000950
AC:
1
AN:
10524
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2645
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3562
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2628
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6041
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53153
Other (OTH)
AF:
0.00
AC:
0
AN:
1506
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.775
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.0000249
AC:
3

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 36 Benign:2
Nov 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 24, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jan 13, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.59
D;.;.;.;.;T
FATHMM_MKL
Benign
0.61
D
LIST_S2
Benign
0.69
T;T;.;T;.;T
M_CAP
Benign
0.046
D
MetaRNN
Benign
0.088
T;T;T;T;T;T
MetaSVM
Benign
-0.72
T
MutationAssessor
Benign
1.9
L;.;.;.;.;.
PhyloP100
1.3
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-2.9
D;.;D;.;.;.
REVEL
Benign
0.089
Sift
Benign
0.043
D;.;D;.;.;.
Sift4G
Uncertain
0.0080
D;D;T;T;T;T
Polyphen
0.77
P;P;P;P;P;.
Vest4
0.43
MutPred
0.40
Gain of MoRF binding (P = 0.0677);.;.;.;.;.;
MVP
0.61
MPC
0.28
ClinPred
0.12
T
GERP RS
4.4
Varity_R
0.38
gMVP
0.31
Mutation Taster
=92/8
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs766772102; hg19: chrX-110970229; API